13F-HR filed by PIPER SANDLER & CO.
PIPER SANDLER & CO. filed this 13F-HR for the quarter ended 2015-12-31, filed 2016-02-16, with 29 holding rows worth $39,405,000.
- Accession
- 0000724683-16-000088
- Filer
- CIK 724683
- Filed
- 2016-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2015
A holdings report, 29 entries on the cover page, a total value of $39,405,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $39,405,000 with VALUE read as thousands by filing date, 13F file number 028-15951. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GENCORP INC | 368682AN0 | SDCV | 7,350,000 | $12,771,000 | thousands by filing date | principal |
| SPY | 78462F103 | SHS | 50,000 | $10,194,000 | thousands by filing date | put |
| VTV THERAPEUTICS INC CL A | 918385105 | Stock | 685,995 | $4,672,000 | thousands by filing date | |
| Energy Select Sector SPDR Fund | 81369Y506 | SHS | 70,000 | $4,222,000 | thousands by filing date | put |
| ROYAL GOLD INC | 780287AA6 | NOTE | 1,801,000 | $1,634,000 | thousands by filing date | principal |
| NEWMONT MINING CORP | 651639AJ5 | NOTE 1.625% 7/1 | 1,206,000 | $1,183,000 | thousands by filing date | principal |
| ARES CAPITAL CORP | 04010LAB9 | CORPORATE OBLIG | 1,005,000 | $1,004,000 | thousands by filing date | principal |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 11,559 | $759,000 | thousands by filing date | |
| SPECTRANETICS CORP | 84760CAA5 | MTNF 2.625% 6/0 | 1,000,000 | $754,000 | thousands by filing date | principal |
| ARES CAP CORP | 04010LAD5 | NOTE 5.125% 6/0 | 500,000 | $499,000 | thousands by filing date | principal |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 3,825 | $481,000 | thousands by filing date | |
| VALEANT PHARMACEUTICALS INTL | 91911K102 | COM | 1,976 | $201,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 5,929 | $180,000 | thousands by filing date | |
| LULULEMON ATHLETICA INC | 550021109 | COM | 3,353 | $176,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 1,385 | $145,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 2,256 | $145,000 | thousands by filing date | |
| APOLLO INVT CORP | 03761UAE6 | NOTE 5.750% 1/1 | 125,000 | $125,000 | thousands by filing date | principal |
| Alcobra Ltd | M2239P109 | SHS | 11,641 | $73,000 | thousands by filing date | |
| RELYPSA INC | 759531106 | Common Stock | 1,702 | $48,000 | thousands by filing date | |
| LDR HLDG CORP | 50185U105 | COM | 1,199 | $30,000 | thousands by filing date | |
| AIRTRAN HLDGS INC | 00949PAD0 | NOTE 5.250%11/0 | 9,000 | $27,000 | thousands by filing date | principal |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 700 | $23,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 201 | $22,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC | 686164104 | COMMON STOCK | 9,809 | $17,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 599 | $16,000 | thousands by filing date | |
| SAGENT PHARMACEUTICALS INC | 786692103 | COM | 185 | $3,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 65 | $1,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 22 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| AURIS MED HLDG AG | H03579101 | COM | 84 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000724683-16-000088 | this filing | 2016-02-16 | acceptance time not in the bulk data set |